Clinical Trial Update: Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09

View source ↗

Summary

Non-interventional substudy to assess natural history of juvenile-onset hypophosphatasia using historical controls from ENB-006-09; completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Disease
• Hypophosphatasia

Drugs mentioned

• ALX-HPP-502

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hypophosphatasia, Bone Disease | Status: COMPLETED | Results posted: 2015-09-28